Valiant Laboratories IPO GMP (Grey market premium)
by 5paisa Research Team
28 Sep 2023
Valiant Lab IPO Details
- Open Date 27-Sep-23
- Close Date 03-Oct-23
- Lot Size 105
- IPO Size ₹ 152.46 Cr
- IPO Price Range ₹ 133 to ₹ 140
- Min Investment ₹ 13965
- Listing Exchange BSE, NSE
- Basis of Allotment 05-Oct-23
- Refunds 06-Oct-23
- Credit to Demat Account 06-Oct-23
- Listing Date 09-Oct-23
Valiant Laboratories IPO Subscription Status
| Date | QIB | NII | Retail | TOTAL |
|---|---|---|---|---|
| 27-Sep-23 | 0.00 | 0.10 | 0.62 | 0.33 |
| 28-Sep-23 | 0.05 | 0.29 | 1.29 | 0.72 |
| 29-Sep-23 | 1.04 | 1.52 | 3.14 | 2.19 |
| 03-Oct-23 | 20.83 | 73.63 | 16.05 | 29.75 |
Valiant Lab IPO Synopsis
Valiant Laboratories Limited IPO is all set to open from 27th September to 3rd October 2023. The company is involved in the business of pharmaceutical ingredient manufacturing with a focus on manufacturing Paracetamol. The IPO includes a fresh issue of 10,890,000 equity shares worth ₹152.46 cr. The share allotment date is 5th October, and the IPO will be listed on 9th October on the stock exchanges. The price band is ₹133 to ₹140 per share and the lot size is 105 shares.
Unistone Capital Pvt Ltd is the book-running lead manager for this IPO, while Link Intime India Private Ltd is the registrar.
Objectives of Valiant Lab IPO:
● To invest in its wholly-owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) for part-financing its capital expenditure requirements in relation to the setting up of a manufacturing facility for specialty chemicals at Saykha Industrial Area, Bharuch, Bharuch, Gujarat (Proposed Facility).
● To invest in VASPL to fund its working capital requirements.
● Fund general corporate purposes.
Valiant Lab IPO Video:
About Valiant Laboratories
Established in 1980, Valiant Laboratories Limited is involved in the business of pharmaceutical ingredient manufacturing with a focus on manufacturing Paracetamol.
The company has its manufacturing facility in Palghar, Maharashtra, spanning over 2,000 square meters of land. This facility has an annual production capacity of 9,000 metric tons. Additionally, the company houses an R&D center featuring an analytical laboratory and resources dedicated to product development.
As of April 30, 2023, Valiant Laboratories employs a workforce of 86 individuals. The company also possesses Good Manufacturing Practices (GMP) for the production and distribution of bulk drugs/API, along with ISO 9001:2015 certification.
Peer Comparison
● Granules India Ltd
● Jagsonpal Pharmaceuticals Ltd
● Alkyl Amines Chemicals Ltd
● Laxmi Organic Industries Ltd
For More Information:
Webstory on Valiant Laboratories IPO
Valiant Laboratories Financial Status
Profit and Loss
Balance Sheet
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Revenue | 333.91 | 291.52 | 182.36 |
| EBITDA | 35.09 | 42.32 | 50.00 |
| PAT | 28.99 | 27.49 | 30.59 |
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Total Assets | 212.76 | 181.81 | 106.31 |
| Share Capital | 32.56 | 16.28 | 10.50 |
| Total Borrowings | 112.26 | 110.35 | 17.73 |
| Particulars (in Rs. Crores) | FY23 | FY22 | FY21 |
|---|---|---|---|
| Net cash generated from / (used in) operating activities | 22.96 | 2.25 | 9.10 |
| Net cash from / (used in) investing activities | -21.18 | -12.24 | -16.67 |
| Net cash flow from / (used in) financing activities | -1.53 | 6.18 | 11.43 |
| Net increase (decrease) in cash and cash equivalents | 0.24 | -3.80 | 3.87 |
Valiant Lab IPO Key Points
-
Strengths
1. The company has reported strong financial performance.
2. The company is working on reducing dependence on the import of raw materials.
3. The company’s Manufacturing Facility is strategically located near JNPT (Nhava Sheva) Port, Maharashtra and its registered office at Mulund West, Mumbai, Maharashtra, which ensures that it has ready access to port facilities and is able to expediently import raw materials and export products in a cost-efficient manner.
4. Highly experienced Management team.
-
Risks
1. The company solely focuses on manufacturing the paracetamol. Thus, any changes in its demand can adversely affect the business.
2. The majority of the operative income is derived from the domestic market.
3. Subject to government regulations.
4. Operates in an intensely competitive industry.
5. Pricing pressure from customers may affect the business.
6. Reforms in the healthcare industry and the uncertainty associated with pharmaceutical pricing and reimbursement could adversely affect the pricing and demand for the company’s products.
7. Restrictions on the import of raw materials may impact the business and results of operations.
8. Higher working capital requirements.
Valiant Lab
How to apply for IPO?
-
Login to your 5paisa account and select the issue in the
current IPO section -
Enter the number of lots and price at which you wish to
apply for -
Enter your UPI ID and click on submit. With this, your
bid will be placed with the exchange -
You will receive a mandate notification to block funds in
your UPI app -
Approve the mandate request on your UPI and funds
will be blocked
Open account in 5 minutes
Be a part of the 5paisa community now with 10 million mobile app users
There is some issue, try later
By Proceeding, you agree T&C*
Valiant Lab IPO FAQs
What is the minimum lot size and investment required for the Valiant Laboratories IPO?
The minimum lot size of Valiant Laboratories IPO is 105 shares and the investment required is ₹13,965.
What is the price band of Valiant Laboratories IPO?
The price band of Valiant Laboratories IPO is ₹133 to ₹140.
When does the Valiant Laboratories IPO opens and closes?
Valiant Laboratories IPO is open from 27th September to 3rd October 2023.
What is the size of the Valiant Laboratories IPO?
The size of Valiant Laboratories IPO is ₹152.46 cr, which includes a fresh issue of 10,890,000 equity shares.
What is the allotment date of the Valiant Laboratories IPO?
The share allotment date of Valiant Laboratories IPO is 5th of October 2023.
What is the Valiant Laboratories IPO listing date?
The Valiant Laboratories IPO will be listed on 9th of October 2023.
Who are the book runners for the Valiant Laboratories IPO?
Unistone Capital Pvt Ltd is the book-running lead manager for Valiant Laboratories IPO.
What is the objective of the Valiant Laboratories IPO?
Valiant Laboratories plans to utilize the raised capital from IPO to:
1. To invest in its wholly-owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) for part-financing its capital expenditure requirements in relation to the setting up of a manufacturing facility for specialty chemicals at Saykha Industrial Area, Bharuch, Bharuch, Gujarat (Proposed Facility).
2. To invest in VASPL to fund its working capital requirements.
3. Fund general corporate purposes.
How to apply for the Valiant Laboratories IPO?
To apply for Valiant Laboratories IPO, follow the steps given below:
● Login to your 5paisa account and select the issue in the current IPO section
● Enter the number of lots and the price at which you wish to apply for the Valiant Laboratories IPO.
● Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
● You will receive a mandate notification to block funds in your UPI app.
Contact Details of Valiant Laboratories IPO
Contact Information
Valiant Laboratories Limited
104,Udyog Kshetra,
Mulund Goregaon Link Road,
Mulund West, Mumbai -400080
Phone: +91 2249712001
Email: complianceofficer@valiantlabs.in
Website: https://valiantlabs.in/
Valiant Laboratories IPO Register
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: valiantlaboratories.ipo@linkintime.co.in
Website: https://linkintime.co.in/mipo/ipoallotment.html
Valiant Laboratories IPO Lead Manager
Unistone Capital Pvt Ltd
IPO Related Articles
